Quantcast

Latest Transplant rejection Stories

2011-05-18 16:39:05

New cell therapy to prevent organ rejection could remove the need for life-long medication and boost the longevity of a transplant for patients Researchers at King's College London have used cells found naturally in the body, to re-educate the immune system to prevent rejection of an organ transplant while remaining capable of fighting infections and cancer. Currently, patients must take immunosuppressant drugs to prevent a new organ from being rejected after transplantation. However, these...

2011-05-04 07:00:00

DURHAM, N.C., May 4, 2011 /PRNewswire/ -- Argos Therapeutics today announced that its immunotherapy platform based on recombinant human soluble CD83 demonstrated significant promise for renal and heart transplantation. Two studies were presented at the 2011 American Transplant Congress meeting in Philadelphia. The first presentation, titled "Enrichment of Regulatory T Cells by Soluble CD83 Associated with Induction of Kidney Allograft Tolerance," detailed the indirect mechanism by...

eb58dc2faf0427d867d18a2b38be3ed61
2011-04-17 07:29:20

Studies of the small sea squirt may ultimately help solve the problem of rejection of organ and bone marrow transplants in humans, according to scientists at UC Santa Barbara. An average of 20 registered patients die every day waiting for transplants, due to the shortage of matching donor organs. More than 110,000 people are currently waiting for organ transplants in the U.S. alone. Currently, only one in 20,000 donors are a match for a patient waiting for a transplant. These grim statistics...

2011-04-15 14:00:18

Kidney transplant recipients who develop antibodies in response to receiving new organs can develop accelerated arteriosclerosis, or narrowing of the arteries that supply blood to the kidney, according to a study appearing in an upcoming issue of the Journal of the American Society Nephrology (JASN). The results indicate that arteriosclerosis resulting from such donor-specific antibodies may play an important role in organ rejection following transplantation. Antibody-mediated transplant...

2011-04-14 12:30:10

For the first time, scientists at Toronto General Hospital, University Health Network have shown in a clinical trial that the Toronto XVIVO System can safely and effectively treat, re-assess and improve the function of high-risk donor lungs so that they can be successfully transplanted into patients. The use of this technique could significantly expand the donor organ pool and improve outcomes after transplantation. In their pioneering work, a team of researchers led by Dr. Shaf Keshavjee,...

2011-04-13 14:07:00

SAN DIEGO, April 13, 2011 /PRNewswire/ -- The engineering of replacement tissue shows promise to dramatically impact the treatment of patients with end stage heart failure. While the field is still in early stages, researchers will discuss the potential for a revolutionary change in medicine at the International Society for Heart & Lung Transplantation Annual Meeting and Scientific Sessions this week. "We have opened the door to generating new complex organs," said Doris A. Taylor,...

2011-03-29 09:54:00

EXTON, Pa., March 29, 2011 /PRNewswire/ -- ViroPharma Incorporated (Nasdaq: VPHM) today announced initiation of a Phase 2 clinical study to evaluate the safety and efficacy of C1 Esterase Inhibitor [Human] for the treatment of acute antibody-mediated rejection (AMR) in recipients of donor-specific cross-match positive kidney transplants. This randomized, double blind, placebo-controlled study will evaluate the safety, tolerability and clinical effect of C1 Esterase Inhibitor [Human] for...

2011-03-24 14:34:32

The impact of traffic air pollution on bronchiolotis obliterans syndrome and mortality after lung transplantation Lung transplant patients have double the risk of organ rejection and death within five years of the procedure if they live near a main road, indicates research published online in Thorax. The Belgian researchers tracked the health of 281 patients who had undergone a lung transplant or retransplant at the same hospital between 1997 and 2008 until 2009. They took into account how...

644c470548d2eee342853c54af2ad6ae1
2011-03-18 06:25:00

A transplant patient in New York has contracted the AIDS virus from the kidney of a living donor, the nation's first case of transmission from a living organ donor since screening for HIV began in the mid-1980s, the New York State Department of Health said on Thursday. The donor had unprotected gay sex in the 11 weeks between the time he tested negative for the AIDS virus and the time the surgery took place in 2009, according to a report issued Thursday by the U.S. Centers of Disease Control...

2011-03-17 12:29:02

WHAT: Sirolimus, a drug currently used to help prevent transplant rejection, can improve lung function and quality of life in individuals living with the lung disease lymphangioleiomyomatosis (LAM), according to the results of a new study sponsored and conducted in part by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health. "Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis," will be published online March 16 in the New England Journal of...


Word of the Day
cruet
  • A vial or small glass bottle, especially one for holding vinegar, oil, etc.; a caster for liquids.
This word is Middle English in origin, and ultimately comes from the Old French, diminutive of 'crue,' flask.
Related